case_images: PMC9393492_01
case_images: Abdominal subcutaneous tissue edema.
case_images: 10.1177_2050313X221118200-fig1.jpg
case_images: PMC9393492_01_10.1177_2050313X221118200-fig1.jpg
case_images: fig1-2050313X221118200
case_images: The anti-Xa level was measured 4 h after the sixth once-daily dose of 40 mg enoxaparin, which was administered to the abdominal wall, as illustrated in Figure 1.
case_images: Deltoid area for SC enoxaparin injection.
case_images: 10.1177_2050313X221118200-fig2.jpg
case_images: PMC9393492_01_10.1177_2050313X221118200-fig2.jpg
case_images: fig2-2050313X221118200
case_images: Figure 2 shows that the enoxaparin 60 mg SC OD administered to the deltoid arms without edema resulted in peak anti-Xa levels of 0.45 and 0.51 IU/mL, respectively.